Stem Cells Archives | Page 4 of 201

How Induced Pluripotent Stem Cells (iPSCs) Are Changing The World As We Know It

June 16, 2026 By Cade Hildreth, Founder & President Leave a Comment

Since their introduction in 2006, iPSCs (or induced pluripotent stem cells) have changed the way we research and treat diseases. In large part, this is thanks to bypassing the ethical concerns associated with embryonic stem cells.

So, why exactly is everyone talking about iPSC applications and their uses within medicine?

If you’re interested in the answer, we’ve made this guide to highlight the ways these stem cells are impacting a wide variety of industries. Let’s get started. [Read more…]

Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2026

June 1, 2026 By Cade Hildreth, Founder & President Leave a Comment

The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has been 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]

10 Biotherapies Books From AABB To Add To Your Reading List In 2026

May 24, 2026 By BioInformant Team Leave a Comment

There is no better time to put together your biotherapies reading list for 2026! In partnership with AABB (Association for the Advancement of Blood & Biotherapies), BioInformant shares 10 must-have technical resources and guides for biotherapies enthusiasts. [Read more…]

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

May 1, 2026 By BioInformant Team Leave a Comment

SEATTLE, WA and CAMBRIDGE, UK — Pluristyx, a leading provider of clinical-grade induced pluripotent stem cell (iPSC) solutions, and Qkine, a pioneer in the manufacture of high-purity, animal-free growth factors and cytokines, today announced a distribution agreement to support streamlined and efficient R&D and manufacturing of differentiated cells and tissues from iPSC. This collaboration will provide researchers, product manufacturers, and therapeutic developers with a streamlined, high-performance workflow, pre-qualified to deliver reliable differentiation of iPSCs into product cells and tissues. [Read more…]

What are Stem Cells? What They Are and What They Do

May 1, 2026 By BioInformant Team 1 Comment

Stem cells can multiply (self-renew) and differentiate into every cell within the human body, giving them enormous potential for use in regenerative medicine. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult humans, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Stem cell research has been going on for over 50 years because stem cells have a unique ability to divide and replicate repeatedly. In addition, their unspecialized nature allows them to become a wide variety of tissue types, which gives them enormous potential for use as living cell therapies. [Read more…]